Advances in mesenchymal stem cell exosomes: a review.

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Cell Biology

Background:

• Mesenchymal stem cells (MSCs) are extensively researched for regenerative medicine and disease treatment.
• Current research prioritizes MSCs for tissue repair and regeneration, utilizing them as seed cells.
• Clinical application of MSCs is hindered by storage constraints and in vitro expansion-induced senescence.

Purpose of the Study:

• To review the acquisition methods, characteristics, biological functions, and clinical applications of exosomes.
• To highlight exosomes as a promising cell-free alternative to MSC transplantation.
• To discuss the advantages of exosomes in targeted delivery, low immunogenicity, and high repairability.

Main Methods:

• Literature review of studies on MSCs and their secreted exosomes.
• Analysis of exosome biogenesis, secretion, and cargo.
• Examination of preclinical and clinical data regarding exosome therapeutic potential.

Main Results:

• Exosomes secreted by MSCs mimic the therapeutic effects of MSCs.
• Exosomes possess advantages over MSCs, including targeted delivery, reduced immunogenicity, and enhanced repair capabilities.
• Exosomes represent a viable cell-free therapeutic approach for various diseases.

Conclusions:

• Exosomes derived from MSCs offer a promising avenue for regenerative medicine, overcoming limitations associated with cell-based therapies.
• Further research into exosome acquisition, characterization, and clinical translation is warranted.
• Exosome-based therapies hold significant potential for advancing disease treatment and tissue regeneration.